# Aromatase Inhibitor Clinical Trial

> **NCT00228956** · — · UNKNOWN · sponsor: **National Institute of General Medical Sciences (NIGMS)** · enrollment: 500 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** pharmacodynamic analysis

## Key facts

- **NCT ID:** NCT00228956
- **Lead sponsor:** National Institute of General Medical Sciences (NIGMS)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2009-02
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2008-09-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00228956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00228956, "Aromatase Inhibitor Clinical Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00228956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*